top of page



Roberto Fagnani, PhD

Chairman & CEO

  • US/EU Venture Funds

    • CoFounder

    • Eli Lilly & Company/Hybritech 

  • University of California

  • US National Cancer Institute

PhD, Pharmacology: University of Milano, Italy

Partha S. Ray, MD

Scientific Advisory Board

  • HCG - Oncology, India

    • Professor and Head of Surgical Oncology

  • University of Illinois College of Medicine, Urbana-Champaign, Illinois

    • Assistant Professor of Surgery
  • John Wayne Cancer Institute​

    • Surgical Oncology Fellowship​​

MD: Drexel University College of Medicine

Gerry Burke

VP Operations

  • Synergy Flow Ltd.

    • Managing Director​

  • Biocept Laboratories Europe Ltd.

    • Managing Director​

  • Boston Scientific, Letterkenny

    • Plant Manager

  • IVT Europe Ltd.

    • Mgr, Intnl Regulatory Affairs​


BS, Microbiology: Queen’s University Belfast

Robert Hussa, PhD 

Director, VP Project Management

  • Adeza Biomedical (Cytyc/Hologic)

    • VP R&D

  • Eli Lilly & Company/Hybritech​

    • VP R&D​​

  • Medical College of Wisconsin

    • ​Professor of OB/Gyn and Biochemistry
  • Indiana University at Indianapolis​

Authored over 100 publications


Ph.D, Biochemistry & Biophysics: Univ of Hawaii

BS, Chemistry: U. Wisconsin - Madison

Terry M. Ryusaki, MT(ASCP)

Chief Commercial Officer

  • CYBIOS Stem Cells

    • CEO

  • ​Morphogen Stem Cells

    • ​President & COO

  • ​Vitagen/Vital Therapies

    • VP Bus Dev & Mkg​

  • Aprogenex​, Inc.

    • VP Sales, Marketing & BD

  • Baxter, Stratus Immunochemistry

    • Director Mktg & Customer Ops

  • Children's Hospital Los Angeles

    • Medical Technologist​


MBA: University of Southern California

BS, Medical Technology: Univ of Hawaii

BA, Microbiology: Univ of Hawaii

Licensed Clinical Lab Scientist:     

    California MTA 28616

bottom of page